Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)

The purpose of this study was to classify patients with severe COVID-19 into more detailed risk groups using coagulation/fibrinolysis, inflammation/immune response, and alveolar/myocardial damage biomarkers, as well as to identify prognostic markers for these patients. These biomarkers were measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikura, Hiroyasu, Maruyama, Junichi, Nakashio, Maiko, Hoshino, Kota, Morimoto, Shinichi, Izutani, Yoshito, Noake, Junta, Yamagaito, Takahiro, Yoshida, Maho, Kitamura, Taisuke, Nakamura, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016182/
https://www.ncbi.nlm.nih.gov/pubmed/36920687
http://dx.doi.org/10.1007/s12185-023-03555-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016182/
https://www.ncbi.nlm.nih.gov/pubmed/36920687
http://dx.doi.org/10.1007/s12185-023-03555-5

Ejemplares similares